FDA Inspection
AndersonBrecon Inc.AndersonBrecon Inc. – FDA Inspection, Feb 25, 2022
Record Details
This FDA Inspection record concerns AndersonBrecon Inc., with an inspection on February 25, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- AndersonBrecon Inc.
- Inspection Date
- February 25, 2022
- Product Type
- Biologics
View Company Profile
ID · 90d459ea-2526-4230-863a-0094a84a4c0b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1163069
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AndersonBrecon Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2025 | Not classified | Chicago District Office | |
| January 10, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 7, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AndersonBrecon Inc.
- FDA Inspection 1271016 - 2025-05-08
- FDA Inspection 1077016 - 2019-01-10
- FDA Inspection 983024 - 2016-07-19
- FDA Inspection 849321 - 2013-09-20
- FDA Inspection 748939 - 2011-10-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.